X
Pfizer backed off, but the price hike game continues
https://pharmaphorum.com/news/pfizer-backed-off-but-the-price-hike-game-continues/
Bristol-Myers Squibb
Clovis and BMS combine cancer drugs in late-stage trials
Clovis and BMS research small molecule and antibody combination.
Is BMS the next pharma takeover target?
Speculation mounting that Pfizer and others could try for $90 bn plus merger
Innate and BMS’ immunotherapy fails in phase 2 trial
French biotech developing cancer immunotherapy with BMS.
BMS suffers further setback in lung cancer
No fast approval for immunotherapy combo in first line use.
Novartis, BMS, Janssen unveil R&D deals
Companies announce eye-catching R&D plans ahead of conference.